Evidence map›Paper›PMID 42375755›Full record

ReviewFood chemistry: X2026

Agronomic, genetic and biotechnological approaches to lower free asparagine content in cereals: state of the art and perspectives.

Elena Baldoni, Marco Napoli, Anna Szafrańska, Slađana Žilić, Delfina Barabaschi, Sonja Ilin, Andrea Tafuri, Antonio Pescatore, Beka Nešković, Viktor Korzun and 2 more

Abstract readReview
In one paragraph

Review in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elena BaldoniNational Research Council (CNR), Institute of Agricultural Biology and Biotechnology (IBBA), Milan, Italy.
Marco NapoliUniversity of Florence, Department of Agriculture, Food, Environment and Forestry (DAGRI), Florence, Italy.
Anna SzafrańskaProf. Waclaw Dabrowski Institute of Agricultural and Food Biotechnology, State Research Institute, Warsaw, Poland.
Slađana ŽilićMaize Research Institute, Food Technology and Biochemistry Group, Zemun Polje, Belgrade, Serbia.
Delfina BarabaschiCouncil for Agricultural Research and Economics (CREA), Research Centre for Genomics and Bioinformatics, Fiorenzuola d'Arda, Italy.
Sonja IlinInstitute of Field and Vegetable Crops, Novi Sad, Serbia.
Andrea TafuriNational Research Council (CNR), Institute of Agricultural Biology and Biotechnology (IBBA), Milan, Italy.
Antonio PescatoreUniversity of Florence, Department of Agriculture, Food, Environment and Forestry (DAGRI), Florence, Italy.
Beka NeškovićMaize Research Institute, Food Technology and Biochemistry Group, Zemun Polje, Belgrade, Serbia.
Viktor KorzunKWS SAAT SE & Co. KGaA, Einbeck, Germany.
Tanya CurtisCurtis Analytics Ltd, Discovery Park, Sandwich, Kent, United Kingdom.
Nigel G HalfordRothamsted Research, Harpenden AL5 2JQ, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acrylamide represents a risk to human health due tο its neurotoxicity and genotoxicity. Acrylamide is formed in a wide range of plant-derived foods during normal high-temperature cooking, and industrial processing at more than 120°C and low humidity. The main chemical process that causes the formation of acrylamide is the "Maillard cascade reactions", which involve reducing sugars and free amino acids that are naturally present in many foods. Free asparagine content is the key factor in acrylamide formation in cereal-derived products. Therefore, breeding for low-asparagine varieties could help to minimize acrylamide-associated risks. In this review, we summarize the state of the art about the agronomic, genetic and biotechnological approaches used so far for decreasing free asparagine levels in cereal grain and propose possible strategies that could be exploited in the future to reach this goal.

Identifiers

PMID42375755
PMCPMC13311785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.